Login / Signup

Reporting of PPI and the MCID in phase III/IV randomised controlled trials-a systematic review.

Joseph BrennanMichael Tin-Chung PoonEdward ChristopherOlivia FultonCarol PorteousPaul M Brennan
Published in: Trials (2023)
Not registered.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • adverse drug
  • protein protein
  • phase ii
  • double blind
  • placebo controlled
  • small molecule
  • emergency department
  • study protocol